Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a life-support technique used in patients with most severe acute respiratory distress syndrome (ARDS). ARDS is a life-threatening form of respiratory failure associated with a mortality rate of approximately 40-45%.Despite several studies confirming a real benefit of the use of ECMO in patients with ARDS who are unresponsive to conventional management, ECMO is still a complex and costly treatment that can be exposed to potential complications, such as nosocomial infections (NI).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Overall incidence of MDR Gram negative bacteria isolations
Timeframe: From ECMO connection up to 48 hours after ECMO de-connection
Incidence of MDR Gram negative bacteria acquired
Timeframe: From ECMO connection up to 48 hours after ECMO de-connection
Incidence of MDR Gram negative bacteria isolated prior to ECMO connection
Timeframe: At study enrollment